Molecular Characterization and Moxifloxacin Susceptibility of <i>Clostridium difficile</i>
In recent years, the incidence and severity of <i>Clostridium difficile</i> infections has increased. Additionally, resistance of <i>C. difficile</i> to frequently used antibiotics is rising. To improve our understanding of <i>C. difficile</i>, there is a need for...
Main Authors: | Sarah Mizrahi, Zohar Hamo, Maya Azrad, Avi Peretz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/8/3/118 |
Similar Items
-
Molecular epidemiology of Clostridium difficile for clinical practice
by: Sarah Tschudin-Sutter
Published: (2014-09-01) -
The Recent Emergence of Clostridium difficile Infection in Romanian Hospitals is Associated with a High Prevalence of Polymerase Chain Reaction Ribotype 027
by: Gabriel Adrian Popescu, et al.
Published: (2018-03-01) -
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients
by: Marcela Krutova, et al.
Published: (2020-06-01) -
Emergence and spread of moxifloxacin-resistant Clostridium difficile ribotype 231 in Sweden between 2006 and 2015
by: H. Harvala, et al.
Published: (2016-11-01) -
<it>Clostridium difficile</it> 027-associated pseudomembranous colitis after short-term treatment with cefuroxime and cephalexin in an elderly orthopedic patient: a case report
by: Søgaard Kirstine, et al.
Published: (2012-10-01)